drugset / Trial / NCT01773096
Methylnaltrexone Use for Opioid-induced Postoperative Constipation
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylnaltrexone | Other / unclassified | 0.15 mg/kg | — |
| Subject | Methylnaltrexone | Other / unclassified | 8 mg | — |
| Subject | Methylnaltrexone | Other / unclassified | 12 mg | — |
| Background | Bisacodyl | Small molecule | — | — |
| Background | Docusate Sodium | Unknown | — | — |
| Background | Senna | Traditional medicine (herbal / TCM) | — | — |
| Background | magnesium hydroxide | Unknown | — | — |
| Background | polyethylene glycol | Other / unclassified | — | — |